Diabetes Insipidus: An Update.
Diabetes insipidus
Polyuria polydipsia syndrome
Primary polydipsia
Journal
Endocrinology and metabolism clinics of North America
ISSN: 1558-4410
Titre abrégé: Endocrinol Metab Clin North Am
Pays: United States
ID NLM: 8800104
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
entrez:
4
8
2020
pubmed:
4
8
2020
medline:
22
6
2021
Statut:
ppublish
Résumé
The differential diagnosis of diabetes insipidus involves the distinction between central or nephrogenic diabetes insipidus and primary polydipsia. Differentiation is important because treatment strategies vary; the wrong treatment can be dangerous. Reliable differentiation is difficult especially in patients with primary polydipsia or partial forms of diabetes insipidus. New diagnostic algorithms are based on the measurement of copeptin after osmotic stimulation by hypertonic saline infusion or after nonosmotic stimulation by arginine and have a higher diagnostic accuracy than the water deprivation test. Treatment involves correcting preexisting water deficits, but is different for central diabetes insipidus, nephrogenic diabetes insipidus, and primary polydipsia.
Identifiants
pubmed: 32741486
pii: S0889-8529(20)30039-6
doi: 10.1016/j.ecl.2020.05.012
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
517-531Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Competing interests M. Christ-Crain received speaking honoraria from Thermo Fisher AG, the manufacturer of the copeptin assay.